摘要
目的:观察长链非编码RNA CASC9对胃癌(gastric cancer,GC)细胞增殖、凋亡以及对5-氟尿嘧啶(5-FU)化疗耐药的影响,并探讨其机制。方法:首先采用实时荧光聚合酶链反应法(real-time polymerase chain reaction,RT-PCR)检测永生化胃上皮细胞(GSE-1)和GC细胞(SGC-7901、BGC-823)中CASC9和P-gp的表达水平;在胃癌细胞SGC-7901和BGC-823中抑制CASC9表达后,通过RT-PCR检测P-gp的表达水平;在胃癌细胞SGC-7901中抑制CASC9表达后,再过表达P-gp,应用CCK-8法检测转染后各组光密度值以评价增殖率,应用Annexin V-APC单染色流式细胞术检测各组转染48 h后的细胞凋亡率,在培养基中加入不同浓度的5-FU检测各组细胞存活率。结果:与正常胃黏膜细胞相比,GC细胞中CASC9、P-gp过表达(P<0.05);抑制CASC9表达后胃癌细胞中P-gp表达下调(P<0.05);胃癌细胞抑制CASC9表达后细胞增殖转移能力明显减弱(P<0.05),凋亡增加(P<0.05),化疗耐药减弱(P<0.05);而过表达P-gp后恶性表型明显恢复(P<0.05)。结论:CASC9可通过促进P-gp的表达调节GC细胞的增殖、凋亡和化疗耐药,参与GC的发生发展。
Objective:To research the role and mechanism of lncRNA CASC9 in proliferation,apoptosis and 5-FU chemotherapy-resistant of gastric cancer(GC)cells.Methods:The expression of CASC9 and P-gp in normal gastric mucosa cells(GSE-1)and GC cells(SGC-7901 and BGC-823)was detected by real-time fluorescent quantitative PCR.The expression of P-gp in SGC-7901 and BGC-823 cells after knockdown CASC9 was examined by RT-PCR.The changes in abilities of proliferation in GC cells after knockdown CASC9 and overexpressed P-gp were examined by CCK-8.Annexin V-APC staining was used to detect the apoptotic rates of each group at 48 h after transfection.Cell viability was detected after transfection and culture with 5-FU.Results:The expression levels of CASC9 and P-gp in GC cells were significantly increased as compared with those in normal gastric mucosa cells(P<0.05 for both).Transfection with si-CASC9 down-regulated P-gp expression(P<0.05).In GC cells,the abilities of proliferation and 5-FU chemotherapy-resistant were significantly reduced and apoptosis was increased after knockdown CASC9(P<0.05).And the overexpression of P-gp can reversed this phenomenon(P<0.05).Conclusion:CASC9 can regulate the proliferation,apoptosis and 5-FU chemotherapy-resistant of GC cells by promoting the expression of P-gp,and adjust the occurrence and development of GC.
作者
鲍晨辉
赵滢
Bao Chenhui;Zhao Ying(Gastrointestinal Nutrition Surgery Department,Shengjing Affiliated Hospital of China Medical University,Liaonig Shenyang 110004,China.)
出处
《现代肿瘤医学》
CAS
2020年第2期195-200,共6页
Journal of Modern Oncology
基金
辽宁省科学技术计划项目(编号:201601122)